期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Smart Resistance Thermometer Sensor Based on C8051F350
1
作者 Jun-guo LIU,An-li TAO,Yun-zhou LI,Li-na HAN,Xiang-zhong LI,Shao-gang LI (School of Information Science and Engineering,Shandong University,qingdao 266510,China) 《Journal of Measurement Science and Instrumentation》 CAS 2010年第S1期107-110,共4页
A Smart resistance thermometer sensor is designed to overcome the shortages of the traditional ones, and Con-form to the world development trend of the sensor market.According to the constitutions of this Smart sensor... A Smart resistance thermometer sensor is designed to overcome the shortages of the traditional ones, and Con-form to the world development trend of the sensor market.According to the constitutions of this Smart sensor and its application coverage,those parts with good -application and low-cost were chosen to constitute this sensor on the basis of full consideration of the linkage among every part.The whole testing system were controlled and processed by C8051F350 single-chip,it could measure precise temperature by PT100 resistance thermometer and circumstance temperature for temperature compensating automatically and simultane-ously,it also could amplify signals to convert analog signals to digital ones,and display results automatically by analysing and processing information.Furthermore,it could auto-compensate self-check,and spot communicate. 展开更多
关键词 C8051F350 single-chip pt100 resistance thermometer Regulators source Communication interface
下载PDF
Platinum drugs:from Pt(Ⅱ)compounds,Pt(Ⅳ)prodrugs,to Pt nanocrystals/nanoclusters 被引量:7
2
作者 Xi Hu Fangyuan Li +1 位作者 Nabila Noor Daishun Ling 《Science Bulletin》 SCIE EI CSCD 2017年第8期589-596,共8页
Platinum(Pt) based drugs, such as cisplatin, are widely used as anti-cancer agents, but their severe adverse reactions and resistance of cancer patients have limited their board clinical use. For the last few decades,... Platinum(Pt) based drugs, such as cisplatin, are widely used as anti-cancer agents, but their severe adverse reactions and resistance of cancer patients have limited their board clinical use. For the last few decades, Pt(Ⅱ) compounds, Pt(Ⅳ) prodrugs as well as smart drug delivery systems have been developed to overcome these problems. However, most conventional strategies rely on the similar anti-cancer mechanism with cisplatin and consequently only achieve limited success. Recently, Pt nanocrystals/nanoclusters(Pt NCs), with a brand new anti-cancer mechanism, have shown a promising potential in targeted cancer therapy, especially in Pt resistance circumvention. This review is helpful to understand the research strategies of Pt drugs, particularly, the recent developments and medical applications of Pt NCs. 展开更多
关键词 Platinum pt(Ⅱ) pt(Ⅳ) pt nanocrystals/nanoclusters pt resistance Cancer therapy
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部